Cover Image
市場調查報告書

全球傳統金屬支架(BMS)市場:開發平台分析

Bare Metal Stents (BMS) - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 217815
出版日期 內容資訊 英文 75 Pages
訂單完成後即時交付
價格
Back to Top
全球傳統金屬支架(BMS)市場:開發平台分析 Bare Metal Stents (BMS) - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年07月04日 內容資訊: 英文 75 Pages
簡介

本報告提供全球及主要國家傳統金屬支架的市場規模與預測,為您彙整競爭趨勢,開發中產品的概要等資料。

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 各開發階段的產品平台
  • 各地區的產品平台
  • 各控管途徑的產品平台
  • 預定核准日別的產品平台
  • 進行中臨床實驗別產品平台

第4章 開發中的產品:各製造廠商

  • 各廠商的各開發階段製品開發平台
  • 各開發階段的產品平台

第5章 廠商及產品概要

  • AlviMedica Medical Technologies Inc.
    • 企業概要
    • 開發中產品及進行中的臨床實驗概要
  • Atrium Medical Corporation
  • Biotronik SE & Co. KG
  • Bolton Medical, Inc.
  • Eurocor GmbH
  • InspireMD, Inc.
  • Japan Stent Technology Co., Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MIV Therapeutics Inc
  • Nesstent Ltd.
  • Nexeon MedSystems, Inc.
  • NuMED, Inc.
  • Palmaz Scientific, Inc.
  • Qvanteq AG
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stentys, SA
  • Svelte Medical Systems, Inc.
  • Vascular Concepts Limited

第6章 最新趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0211EPD

GlobalData's Medical Devices sector report, "Bare Metal Stents (BMS) - Medical Devices Pipeline Assessment, 2016" provides an overview of Bare Metal Stents (BMS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bare Metal Stents (BMS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Bare Metal Stents (BMS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bare Metal Stents (BMS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bare Metal Stents (BMS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Bare Metal Stents (BMS) Overview

3. Products under Development

  • 3.1. Bare Metal Stents (BMS) - Pipeline Products by Stage of Development
  • 3.2. Bare Metal Stents (BMS) - Pipeline Products by Territory
  • 3.3. Bare Metal Stents (BMS) - Pipeline Products by Regulatory Path
  • 3.4. Bare Metal Stents (BMS) - Pipeline Products by Estimated Approval Date
  • 3.5. Bare Metal Stents (BMS) - Ongoing Clinical Trials

4. Bare Metal Stents (BMS) - Pipeline Products under Development by Companies

  • 4.1. Bare Metal Stents (BMS) Companies - Pipeline Products by Stage of Development
  • 4.2. Bare Metal Stents (BMS) - Pipeline Products by Stage of Development

5. Bare Metal Stents (BMS) Companies and Product Overview

  • 5.1. AlviMedica Medical Technologies Inc. Company Overview
    • 5.1.1. AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Atrium Medical Corporation Company Overview
    • 5.2.1. Atrium Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Biotronik SE & Co. KG Company Overview
    • 5.3.1. Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Bolton Medical, Inc. Company Overview
    • 5.4.1. Bolton Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Boston Scientific Corporation Company Overview
    • 5.5.1. Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. InspireMD, Inc. Company Overview
    • 5.6.1. InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. ITGI Medical Ltd. Company Overview
    • 5.7.1. ITGI Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Medtronic plc Company Overview
    • 5.8.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Meril Life Sciences Pvt. Ltd. Company Overview
    • 5.9.1. Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. MIV Therapeutics Inc Company Overview
    • 5.10.1. MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Nesstent Ltd. Company Overview
    • 5.11.1. Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Nexeon MedSystems, Inc. Company Overview
    • 5.12.1. Nexeon MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Palmaz Scientific, Inc. Company Overview
    • 5.13.1. Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Qvanteq AG Company Overview
    • 5.14.1. Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • 5.15.1. Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Stentys SA Company Overview
    • 5.16.1. Stentys SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Svelte Medical Systems, Inc. Company Overview
    • 5.17.1. Svelte Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Vascular Concepts Limited Company Overview
    • 5.18.1. Vascular Concepts Limited Pipeline Products & Ongoing Clinical Trials Overview

6. Bare Metal Stents (BMS)- Recent Developments

  • 6.1. Jun 29, 2016: InspireMD Prices Public Offering of Preferred Stock and Warrants for USD14.6 Million
  • 6.2. Jun 17, 2016: ARIAD Completes Strategic Review and Announces Plans for Growth
  • 6.3. Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation
  • 6.4. Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day
  • 6.5. May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results
  • 6.6. May 24, 2016: ARIAD Announces Appointment of Jennifer L. Herron as Chief Commercial Officer
  • 6.7. May 10, 2016: InspireMD Reports Financial Results for the First Quarter Ended March 31, 2016
  • 6.8. May 10, 2016: ARIAD Reports First Quarter 2016 Financial Results and Progress on Strategic Review
  • 6.9. May 02, 2016: B. Braun Interventional Systems Extends Exclusive U.S. Distribution Agreement with NuMED
  • 6.10. Apr 20, 2016: Abbott Reports First-Quarter 2016 Results
  • 6.11. Apr 01, 2016: MicroPort and Yizheng Municipal Government Establishes "Shanghai-Yizheng Healthcare Cooperation Project"
  • 6.12. Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device
  • 6.13. Mar 21, 2016: NIRTRAKS Study of a Novel Coronary Stent Enrolls Its First Patient
  • 6.14. Jan 28, 2016: STENTYS: First Intervention with the Self-Apposing Drug-Eluting Stent for Lower Limbs Broadcasted Live at LINC International Congress
  • 6.15. Nov 21, 2015: The Registration has been approved in Philippines for WALTZ Cobalt Alloy Stent System
  • 6.16. Oct 21, 2015: Abbott Reports Third-Quarter 2015 Results
  • 6.17. Aug 03, 2015: Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016
  • 6.18. Jul 22, 2015: Abbott Reports Second-Quarter 2015 Results

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Bare Metal Stents (BMS) - Pipeline Products by Stage of Development
  • Table 2: Bare Metal Stents (BMS) - Pipeline Products by Territory
  • Table 3: Bare Metal Stents (BMS) - Pipeline Products by Regulatory Path
  • Table 4: Bare Metal Stents (BMS) - Pipeline Products by Estimated Approval Date
  • Table 5: Bare Metal Stents (BMS) - Ongoing Clinical Trials
  • Table 6: Bare Metal Stents (BMS) Companies - Pipeline Products by Stage of Development
  • Table 7: Bare Metal Stents (BMS) - Pipeline Products by Stage of Development
  • Table 8: AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: BMS - Avantgarde - Product Status
  • Table 10: BMS - Avantgarde - Product Description
  • Table 11: BMS - Chrono - Product Status
  • Table 12: BMS - Chrono - Product Description
  • Table 13: Tecnic Plus - Product Status
  • Table 14: Tecnic Plus - Product Description
  • Table 15: Atrium Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Next Generation Super Flexible Cobalt Chromium Coronary Stent - Product Status
  • Table 17: Next Generation Super Flexible Cobalt Chromium Coronary Stent - Product Description
  • Table 18: Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: AMS-1 - Product Status
  • Table 20: AMS-1 - Product Description
  • Table 21: AMS-2 - Product Status
  • Table 22: AMS-2 - Product Description
  • Table 23: Bolton Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Spiral Force - Product Status
  • Table 25: Spiral Force - Product Description
  • Table 26: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: INNOVA Self-Expanding Bare-Metal Stent System - Product Status
  • Table 28: INNOVA Self-Expanding Bare-Metal Stent System - Product Description
  • Table 29: Boston Scientific Corporation - Ongoing Clinical Trials Overview
  • Table 30: INNOVA Self-Expanding Bare-Metal Stent System - Korean Multicenter Registry of INNOVA Stent for Femoropopliteal Artery Disease: (K-INNOVA Registry)
  • Table 31: InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: MGuard Prime EPS - Product Status
  • Table 33: MGuard Prime EPS - Product Description
  • Table 34: ITGI Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Aneugraft Dx - Product Status
  • Table 36: Aneugraft Dx - Product Description
  • Table 37: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Twin-Rail - Product Status
  • Table 39: Twin-Rail - Product Description
  • Table 40: Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: Crypton Stainless Steel Coronary Stent System - Product Status
  • Table 42: Crypton Stainless Steel Coronary Stent System - Product Description
  • Table 43: NEXGEN Cobalt Chromium Coronary Stent System - Product Status
  • Table 44: NEXGEN Cobalt Chromium Coronary Stent System - Product Description
  • Table 45: MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Vestapor - Product Status
  • Table 47: Vestapor - Product Description
  • Table 48: Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: NesStent's New Stent - Product Status
  • Table 50: NesStent's New Stent - Product Description
  • Table 51: Nexeon MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: PROTEX Coronary Stent System - Product Status
  • Table 53: PROTEX Coronary Stent System - Product Description
  • Table 54: RIVIERA Coronary Stent System - Product Status
  • Table 55: RIVIERA Coronary Stent System - Product Description
  • Table 56: Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Micro-Grooved Coronary Stent - Product Status
  • Table 58: Micro-Grooved Coronary Stent - Product Description
  • Table 59: Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Qstent - Product Status
  • Table 61: Qstent - Product Description
  • Table 62: Qvanteq AG - Ongoing Clinical Trials Overview
  • Table 63: Qstent - Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation
  • Table 64: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Bare Metal Coronary Stent - Product Status
  • Table 66: Bare Metal Coronary Stent - Product Description
  • Table 67: Stentys SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: STENTYS Self-Apposing Coronary Stent - Product Status
  • Table 69: STENTYS Self-Apposing Coronary Stent - Product Description
  • Table 70: Svelte Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: Svelte Acrobat System - Product Status
  • Table 72: Svelte Acrobat System - Product Description
  • Table 73: Vascular Concepts Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: ProLink LP - Product Status
  • Table 75: ProLink LP - Product Description
  • Table 76: ProLink SV - Product Status
  • Table 77: ProLink SV - Product Description
  • Table 78: ProPass - Product Status
  • Table 79: ProPass - Product Description
  • Table 80: ProZeta - Product Status
  • Table 81: ProZeta - Product Description
  • Table 82: Glossary

List of Figures

  • Figure 1: Bare Metal Stents (BMS) - Pipeline Products by Stage of Development
  • Figure 2: Bare Metal Stents (BMS) - Pipeline Products by Territory
  • Figure 3: Bare Metal Stents (BMS) - Pipeline Products by Regulatory Path
  • Figure 4: Bare Metal Stents (BMS) - Pipeline Products by Estimated Approval Date
  • Figure 5: Bare Metal Stents (BMS) - Ongoing Clinical Trials
Back to Top